Ovid Therapeutics

1.60
+0.15
+10.34%
OVID
 1.61 1.45 157.88万股总市值 2.08亿
 1.45 1.21% 244.02万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
Ovid Therapeutics(OVID)
01-30 09:05  
$Ovid Therapeutics(OVID)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001315863-26-000096  Act: 34  Size: 14 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
01-09 01:05  
$Ovid Therapeutics(OVID)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001623632-26-000052  Act: 34  Size: 45 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
01-06 07:05  
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002036798-26-000002  Size: 5 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
01-06 05:15  
$Ovid Therapeutics(OVID)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-26-000036  Act: 34  Size: 18 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-23 19:05  
$Ovid Therapeutics(OVID)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003891  Act: 33  Size: 1 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-23 05:35  
$Ovid Therapeutics(OVID)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-25-328805  Act: 33  Size: 184 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-19 07:15  
$Ovid Therapeutics(OVID)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001346824-25-000079  Act: 34  Size: 19 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-19 05:25  
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001256153-25-000004  Size: 15 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-19 05:15  
$Ovid Therapeutics(OVID)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001315863-25-000859  Act: 34  Size: 13 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-18 21:45  
$Ovid Therapeutics(OVID)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-323798  Act: 34  Size: 174 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-16 06:35  
$Ovid Therapeutics(OVID)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-25-319453  Act: 33  Size: 416 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-12 03:05  
$Ovid Therapeutics(OVID)$ 8-K Current report, item 5.07 Accession Number: 0001636651-25-000017  Act: 34  Size: 154 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-10 10:25  
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001395064-25-000172  Size: 10 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-10 10:05  
$Ovid Therapeutics(OVID)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001395064-25-000167  Act: 34  Size: 20 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-12-09 00:55  
$Ovid Therapeutics(OVID)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000340  Act: 34  Size: 9 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-11-12 20:15  
$Ovid Therapeutics(OVID)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001636651-25-000012  Act: 34  Size: 7 MB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-11-12 20:05  
$Ovid Therapeutics(OVID)$ 8-K Current report, items 2.02, 5.02, and 9.01 Accession Number: 0001636651-25-000011  Act: 34  Size: 267 KB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-11-07 19:15  
$Ovid Therapeutics(OVID)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-25-040884  Act: 34  Size: 1 MB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-10-28 18:05  
$Ovid Therapeutics(OVID)$ PRE 14A Other preliminary proxy statements Accession Number: 0001140361-25-039516  Act: 34  Size: 1 MB 网页链接
用户头像
Ovid Therapeutics(OVID)
2025-10-28 05:35  
$Ovid Therapeutics(OVID)$ PREM14A Preliminary proxy statements relating to merger or acquisition Accession Number: 0001140361-25-039497  Act: 34  Size: 1 MB 网页链接